Literature DB >> 23459606

How can resistant hypertension be identified and prevented?

Anna Solini1, Luis M Ruilope.   

Abstract

Resistant hypertension is highly prevalent, and is the form of arterial hypertension that is most difficult to treat. Many patients diagnosed with this disease do not have resistant hypertension, but rather have mismanaged primary hypertension. In many cases blood pressure can be controlled by directly addressing underlying causes such as primary aldosteronism, obstructive sleep apnoea, or excessive neurogenic stimulation. Clinicians should ensure that appropriate blood-pressure measurements are used to diagnose resistant hypertension, explore a variety of drug combinations, and battle clinical inertia. Patients should comply with medication schedules and dietary modifications. Correction of these factors will greatly diminish the prevalence of 'resistant' hypertension and avoid the consequences of a persistently elevated blood pressure in these patients.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23459606     DOI: 10.1038/nrcardio.2013.23

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN: 1759-5002            Impact factor:   32.419


  42 in total

1.  Sodium, blood pressure, and cardiovascular disease: further evidence supporting the American Heart Association sodium reduction recommendations.

Authors:  Paul K Whelton; Lawrence J Appel; Ralph L Sacco; Cheryl A M Anderson; Elliott M Antman; Norman Campbell; Sandra B Dunbar; Edward D Frohlich; John E Hall; Mariell Jessup; Darwin R Labarthe; Graham A MacGregor; Frank M Sacks; Jeremiah Stamler; Dorothea K Vafiadis; Linda V Van Horn
Journal:  Circulation       Date:  2012-11-02       Impact factor: 29.690

2.  Relationship of alcohol consumption to 7-year blood pressure change in Japanese men.

Authors:  Katsushi Yoshita; Katsuyuki Miura; Yuko Morikawa; Masao Ishizaki; Teruhiko Kido; Yuchi Naruse; Yoshiyuki Soyama; Yasushi Suwazono; Koji Nogawa; Hideaki Nakagawa
Journal:  J Hypertens       Date:  2005-08       Impact factor: 4.844

3.  Strong protective effect of the aldehyde dehydrogenase gene (ALDH2) 504lys (*2) allele against alcoholism and alcohol-induced medical diseases in Asians.

Authors:  Dawei Li; Hongyu Zhao; Joel Gelernter
Journal:  Hum Genet       Date:  2011-11-20       Impact factor: 4.132

Review 4.  Resistant hypertension, obstructive sleep apnoea and aldosterone.

Authors:  T Dudenbostel; D A Calhoun
Journal:  J Hum Hypertens       Date:  2011-06-09       Impact factor: 3.012

5.  Obstructive sleep apnea: the most common secondary cause of hypertension associated with resistant hypertension.

Authors:  Rodrigo P Pedrosa; Luciano F Drager; Carolina C Gonzaga; Marcio G Sousa; Lílian K G de Paula; Aline C S Amaro; Celso Amodeo; Luiz A Bortolotto; Eduardo M Krieger; T Douglas Bradley; Geraldo Lorenzi-Filho
Journal:  Hypertension       Date:  2011-10-03       Impact factor: 10.190

6.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  Hypertension       Date:  2003-12-01       Impact factor: 10.190

7.  Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents.

Authors:  Paolo Mulatero; Michael Stowasser; Keh-Chuan Loh; Carlos E Fardella; Richard D Gordon; Lorena Mosso; Celso E Gomez-Sanchez; Franco Veglio; William F Young
Journal:  J Clin Endocrinol Metab       Date:  2004-03       Impact factor: 5.958

8.  When more is not better: treatment intensification among hypertensive patients with poor medication adherence.

Authors:  Michele Heisler; Mary M Hogan; Timothy P Hofer; Julie A Schmittdiel; Manel Pladevall; Eve A Kerr
Journal:  Circulation       Date:  2008-05-27       Impact factor: 29.690

9.  Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research.

Authors:  David A Calhoun; Daniel Jones; Stephen Textor; David C Goff; Timothy P Murphy; Robert D Toto; Anthony White; William C Cushman; William White; Domenic Sica; Keith Ferdinand; Thomas D Giles; Bonita Falkner; Robert M Carey
Journal:  Hypertension       Date:  2008-04-07       Impact factor: 10.190

10.  The clock is ticking: the case for achieving more rapid control of hypertension.

Authors:  Dan R Berlowitz; Stanley Franklin
Journal:  J Clin Hypertens (Greenwich)       Date:  2010-05       Impact factor: 3.738

View more
  5 in total

1.  Sacubitril/valsartan in the treatment of arterial hypertension: an unaccomplished promise?

Authors:  Gema Ruiz-Hurtado; Luis M Ruilope
Journal:  Hypertens Res       Date:  2017-03-09       Impact factor: 3.872

Review 2.  Dysfunctional brain-bone marrow communication: a paradigm shift in the pathophysiology of hypertension.

Authors:  Monica M Santisteban; Jasenka Zubcevic; David M Baekey; Mohan K Raizada
Journal:  Curr Hypertens Rep       Date:  2013-08       Impact factor: 5.369

Review 3.  The efficacy of antihypertensive drugs in chronic intermittent hypoxia conditions.

Authors:  Lucilia N Diogo; Emília C Monteiro
Journal:  Front Physiol       Date:  2014-09-22       Impact factor: 4.566

Review 4.  Chinese herbal medicine for resistant hypertension: a systematic review.

Authors:  Xingjiang Xiong; Xiaoke Li; Yuqing Zhang; Jie Wang
Journal:  BMJ Open       Date:  2015-01-30       Impact factor: 2.692

5.  Screening for obstructive sleep apnea syndrome in hypertensive outpatients: clinical characteristics of hypertension are important for their analysis.

Authors:  Tomoyuki Kawada
Journal:  J Clin Hypertens (Greenwich)       Date:  2013-08-07       Impact factor: 3.738

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.